Search by Drug Name or NDC
NDC 63323-0850-04 Moxifloxacin 400 mg/250mL Details
Moxifloxacin 400 mg/250mL
Moxifloxacin is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is MOXIFLOXACIN HYDROCHLORIDE.
MedlinePlus Drug Summary
Moxifloxacin injection is used to treat certain infections caused by bacteria such as pneumonia; and skin and abdominal (stomach area) infections. Moxifloxacin injection is also used to prevent and treat plague (a serious infection that may be spread on purpose as part of a bioterror attack. Moxifloxacin injection may also be used to treat bronchitis or sinus infections but should not be used for these conditions if there are other treatment options available. Moxifloxacin injection is in a class of antibiotics called fluoroquinolones. It works by killing the bacteria that cause infections. Antibiotics such as moxifloxacin injection will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 63323-0850-04Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Moxifloxacin Injection
Product Information
| NDC | 63323-0850 |
|---|---|
| Product ID | 63323-850_78ddbe5e-f994-4167-8e9f-ecc3108a284b |
| Associated GPIs | 05000037102020 |
| GCN Sequence Number | 074502 |
| GCN Sequence Number Description | moxifloxacin/sod.ace,sul/water PIGGYBACK 400MG/.25L INTRAVEN |
| HIC3 | W1Q |
| HIC3 Description | QUINOLONE ANTIBIOTICS |
| GCN | 39172 |
| HICL Sequence Number | 042339 |
| HICL Sequence Number Description | MOXIFLOXACIN HCL IN SODIUM ACETATE AND SULFATE,WATER,ISO-OSM |
| Brand/Generic | Generic |
| Proprietary Name | Moxifloxacin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | MOXIFLOXACIN HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 400 |
| Active Ingredient Units | mg/250mL |
| Substance Name | MOXIFLOXACIN HYDROCHLORIDE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Quinolone Antimicrobial [EPC], Quinolones [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA205572 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0850-04 (63323085004)
| NDC Package Code | 63323-850-04 |
|---|---|
| Billing NDC | 63323085004 |
| Package | 12 BAG in 1 CASE (63323-850-04) / 250 mL in 1 BAG (63323-850-74) |
| Marketing Start Date | 2015-03-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |